Table 3.
Number of cells | ||||
---|---|---|---|---|
# | Epi | PrE | Total | |
Fgfr1+/+; Pdgfra+/+ | 6 | 14 ± 2 | 30 ± 5 | 156 ± 14 |
Fgfrr−/−; Pdgfra+/+ | 5 | 23 ± 4 | 20 ± 6 | 161 ± 11 |
Fgfr1+/+; Pdgfra−/− | 10 | 13 ± 1 | 20 ± 3 | 156 ± 9 |
Fgfr1+/−; Pdgfra−/− | 5 | 22 ± 4 | 19 ± 2 | 163 ± 31 |
Fgfr1−/−; Pdgfra+/− | 5 | 21 ± 4 | 8 ± 3* | 148 ± 17 |
Fgfr1−/−; Pdgfra−/− | 3 | 19 ± 8 | 0 ± 0** | 51 ± 12 |
Notes:
, p=0.002;
, p=0.003 when compared to wild-type control